Parallax Volatility Advisers
ANIP icon

Parallax Volatility Advisers’s ANI Pharmaceuticals ANIP Stock Holding History

Parallax Volatility Advisers’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-5,000
Closed -$310K – 2805
2015
Q2 		$310K Buy
+5,000
New +$298K ﹤0.01% 1832

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Parallax Volatility Advisers's ANIP Position: Q1 2018 in Review

Parallax Volatility Advisers sold out of ANI Pharmaceuticals (ANIP) in Q1 2018, closing a stake of 1,260 shares — an estimated $81K sold.

Parallax Volatility Advisers first reported a position in ANIP in Q4 2017 and held it in 1 quarter. The position peaked at $81K in Q4 2017. 175 funds tracked by Wall St. Rank hold ANIP as of Q1 2018.

  • Parallax Volatility Advisers reported no remaining ANI Pharmaceuticals position as of Q1 2018 after selling out during the quarter.
  • Parallax Volatility Advisers sold 1,260 ANI Pharmaceuticals shares in Q1 2018, an estimated $81K.
  • Parallax Volatility Advisers first reported a position in ANI Pharmaceuticals in Q4 2017 and held it in 1 quarter.
  • Parallax Volatility Advisers's ANI Pharmaceuticals position peaked at $81K in Q4 2017.
  • 175 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q1 2018.

Based on Parallax Volatility Advisers's 13F filing for Q1 2018, filed 15 May 2018.